Statistics for PD-L1 in systemic immunity: unraveling its contribution to PD-1/PD-L1 blockade immunotherapy
Total visits
views | |
---|---|
PD-L1 in systemic immunity: unraveling its contribution to PD-1/PD-L1 blockade immunotherapy | 190 |
Total visits per month
views | |
---|---|
February 2025 | 1 |
March 2025 | 0 |
April 2025 | 0 |
May 2025 | 0 |
June 2025 | 0 |
July 2025 | 0 |
August 2025 | 0 |
File Visits
views | |
---|---|
2020101605_Bocanegra_PDL1.pdf | 211 |
Top country views
views | |
---|---|
United States | 117 |
China | 15 |
Sweden | 8 |
Czechia | 6 |
Germany | 4 |
United Kingdom | 4 |
Australia | 3 |
Spain | 3 |
Ireland | 3 |
India | 2 |
Japan | 2 |
Russia | 2 |
Ukraine | 2 |
Jordan | 1 |
South Korea | 1 |
Portugal | 1 |
Slovenia | 1 |
Slovakia | 1 |
Top city views
views | |
---|---|
Ashburn | 32 |
Fairfield | 20 |
Oakland | 12 |
San Diego | 8 |
Ann Arbor | 7 |
Wilmington | 7 |
Cambridge | 6 |
Houston | 5 |
Roznov | 5 |
Guangzhou | 4 |
Mountain View | 3 |
Fuzhou | 2 |
Nanjing | 2 |
Redmond | 2 |
Redwood City | 2 |
Shenyang | 2 |
Silver Spring | 2 |
Andover | 1 |
Bratislava | 1 |
Fremont | 1 |
Fukui | 1 |
Hangzhou | 1 |
London | 1 |
Madrid | 1 |
Menlo Park | 1 |
Mumbai | 1 |
Nanning | 1 |
Rochester | 1 |
San Pedro | 1 |
Thousand Oaks | 1 |
Tobolsk | 1 |
Wuhan | 1 |
Yecla | 1 |